SEC Form D · filed March 12, 2021
Janux Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Peter Thompson, M.D · La Jolla, CADirectorDavid Campbell, Ph.D · La Jolla, CAExec · DirectorTighe J. Reardon · La Jolla, CAExecJake Simson, Ph.D · La Jolla, CADirectorJay Lichter, Ph.D · La Jolla, CADirectorStefan Heller · La Jolla, CADirectorMelissa Walters · Houston, TXDirectorSignalfire Opportunities GP, LLC Series 15 · SAN FRANCISCO, CAExecTheodore Pritchett Iii · Houston, TXExec · DirectorGenevieve Hedrick · SAN DIEGO, CADirectorMatthew Blanchard · SAN DIEGO, CADirectorStacey P. Kirkconnell · Grand Cayman, Cayman IslandsDirectorWord D. Peake · New York, NYExecRichard W. Wiltshire · NEW YORK, NYDirectorArnon Dinur · New York, NYDirectorGigi Levy-Weisss · New York, NYDirectorMike Mcneil · San Francisco, CADirectorSytse Sijbrandij · San Francisco, CAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗